Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2012 Filed Feb 9, 2012 21:39 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 65,693 | $52.03 | $3,418,006.79 |
DisclosureSEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 3 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,315.546 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 38,440. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:39 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
GrantCommon Stock | 153,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 2 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,008.546 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:39 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
GrantCommon Stock | 38,440 | $52.03 | $2,000,033.20 |
DisclosureSEC source: 0001209191-12-008712 · doc4.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,162.546 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:40 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 15,752 | $52.03 | $819,576.56 |
DisclosureSEC source: 0001209191-12-008716 · doc4.xml · nonDerivative · entry 3 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,624.532 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 9,610. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:40 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 36,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008716 · doc4.xml · nonDerivative · entry 2 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,376.532 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:40 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
GrantCommon Stock | 9,610 | $52.03 | $500,008.30 |
DisclosureSEC source: 0001209191-12-008716 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,488.532 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:40 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
GrantCommon Stock | 43,245 | $52.03 | $2,250,037.35 |
DisclosureSEC source: 0001209191-12-008717 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,088.085 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 43,245. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:41 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 32,847 | $52.03 | $1,709,029.41 |
DisclosureSEC source: 0001209191-12-008719 · doc4.xml · nonDerivative · entry 3 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,171.552 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 19,220. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:41 UTC |
Sweere LoriEVP, Human Capital
|
GrantCommon Stock | 76,924 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008719 · doc4.xml · nonDerivative · entry 2 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,018.552 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:41 UTC |
Sweere LoriEVP, Human Capital
|
GrantCommon Stock | 19,220 | $52.03 | $1,000,016.60 |
DisclosureSEC source: 0001209191-12-008719 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,094.552 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
GrantCommon Stock | 19,220 | $52.03 | $1,000,016.60 |
DisclosureSEC source: 0001209191-12-008721 · doc4.xml · nonDerivative · entry 1 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,262.866 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 19,220. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 64,924 | $52.03 | $3,377,995.72 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,591.012 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 38,440. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
GrantCommon Stock | 153,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,515.012 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:42 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
GrantCommon Stock | 38,440 | $52.03 | $2,000,033.20 |
DisclosureSEC source: 0001209191-12-008722 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,669.012 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:43 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
Tax withholdingCommon Stock | 65,693 | $52.03 | $3,418,006.79 |
DisclosureSEC source: 0001209191-12-008723 · doc4.xml · nonDerivative · entry 3 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,095.267 F3 · shares: Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2009-2011. F4 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 7, 2012, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 43,245. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:43 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 153,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-008723 · doc4.xml · nonDerivative · entry 2 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,788.267 F2 · shares: Represents the settlement of Performance Share Awards for the performance period 2009-2011. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:43 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
GrantCommon Stock | 43,245 | $52.03 | $2,250,037.35 |
DisclosureSEC source: 0001209191-12-008723 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,942.267 F1 · shares: The restricted stock units will vest at a rate of 33% on December 28, 2012; February 7, 2014; and February 7, 2015. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:45 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 4,106 | $51.31 | $210,678.86 |
DisclosureSEC source: 0001209191-12-008166 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,999.327 Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:45 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
Tax withholdingCommon Stock | 4,508 | $51.31 | $231,305.48 |
DisclosureSEC source: 0001209191-12-008168 · doc4.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,608,964.872 Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:46 UTC |
MUNSELL WILLIAM AEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 3,005 | $51.31 | $154,186.55 |
DisclosureSEC source: 0001209191-12-008169 · doc4.xml · nonDerivative · entry 1 MUNSELL WILLIAM A · CIK 0001308194 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,722.546 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:47 UTC |
RANGEN ERIC SSr VP & Chief Acctg Officer
|
Tax withholdingCommon Stock | 773 | $51.31 | $39,662.63 |
DisclosureSEC source: 0001209191-12-008170 · doc4.xml · nonDerivative · entry 1 RANGEN ERIC S · CIK 0001175737 · Sr VP & Chief Acctg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,878.532 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:47 UTC |
RENFRO LARRY CEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 9,439 | $51.31 | $484,315.09 |
DisclosureSEC source: 0001209191-12-008171 · doc4.xml · nonDerivative · entry 1 RENFRO LARRY C · CIK 0001235046 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,843.085 Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:49 UTC |
Sweere LoriEVP, Human Capital
|
Tax withholdingCommon Stock | 1,603 | $51.31 | $82,249.93 |
DisclosureSEC source: 0001209191-12-008174 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,874.552 Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:50 UTC |
Tuckson Reed VaughnEVP & Chief of Medical Affairs
|
Tax withholdingCommon Stock | 3,005 | $51.31 | $154,186.55 |
DisclosureSEC source: 0001209191-12-008175 · doc4.xml · nonDerivative · entry 1 Tuckson Reed Vaughn · CIK 0001511051 · EVP & Chief of Medical Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,042.866 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:51 UTC |
WELTERS ANTHONYEVP, UnitedHealth Group
|
Tax withholdingCommon Stock | 2,957 | $51.31 | $151,723.67 |
DisclosureSEC source: 0001209191-12-008176 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,229.012 F1 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2012 Filed Feb 7, 2012 21:51 UTC |
WICHMANN DAVID SEVP & CFO, Pres UHG Operations
|
Tax withholdingCommon Stock | 3,152 | $51.31 | $161,729.12 |
DisclosureSEC source: 0001209191-12-008177 · doc4.xml · nonDerivative · entry 1 WICHMANN DAVID S · CIK 0001268489 · EVP & CFO, Pres UHG Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,697.267 Read SEC document |
| February 01, 2012 Filed Feb 2, 2012 21:38 UTC |
Sweere LoriEVP, Human Capital
|
SaleCommon Stock | 10,282 | $53.19 | $546,931.45 |
DisclosureSEC source: 0001209191-12-006993 · doc4.xml · nonDerivative · entry 1 Sweere Lori · CIK 0001407932 · EVP, Human Capital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,477.552 F1 · price: This transaction was executed in multiple trades ranging from $53.15476 to $53.25 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| January 30, 2012 Filed Jan 30, 2012 21:43 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionNon-qualified stock option (right to buy) · Derivative | 2,120 | $0.00 Strike: $18.89 | $0.00 |
DisclosureSEC source: 0001209191-12-006104 · doc4.xml · derivative · entry 3 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,120 shares Expires 2012-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2012 Filed Jan 30, 2012 21:43 UTC |
BURKE RICHARD TDirector
|
Exercise / conversionCommon Stock | 2,120 | $18.89 | $40,046.80 |
DisclosureSEC source: 0001209191-12-006104 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,511,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 38,307 | $52.89 | $2,026,214.29 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 8 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,105.327 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades ranging from $52.75 to $53.077 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionStock Appreciation Rights · Derivative | 19,006 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · derivative · entry 13 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,018 Underlying: Common Stock · 19,006 shares Expires 2020-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 9 from the years 2011 through 2014. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionStock Appreciation Rights · Derivative | 56,562 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · derivative · entry 12 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,560 Underlying: Common Stock · 56,562 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 23 from the years 2010 through 2013. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionStock Appreciation Rights · Derivative | 96,825 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · derivative · entry 11 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,275 Underlying: Common Stock · 96,825 shares Expires 2018-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 14,946 | $52.62 | $786,458.52 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 7 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,412.327 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionCommon Stock | 19,006 | $33.00 | $627,198.00 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 6 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,358.327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 42,470 | $52.62 | $2,234,771.40 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 5 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,352.327 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionCommon Stock | 56,562 | $29.74 | $1,682,153.88 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 4 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,822.327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Tax withholdingCommon Stock | 75,290 | $52.62 | $3,961,759.80 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 3 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,260.327 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
Exercise / conversionCommon Stock | 96,825 | $33.94 | $3,286,240.50 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,550.327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| January 11, 2012 Filed Jan 13, 2012 22:30 UTC |
BOUDREAUX GAILEVP & CEO, UnitedHealthcare
|
SaleCommon Stock | 68,095 | $52.32 | $3,563,009.59 |
DisclosureSEC source: 0001209191-12-003658 · doc4.xml · nonDerivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · EVP & CEO, UnitedHealthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,725.327 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades ranging from $52.06 to $52.40 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:01 UTC |
BALLARD WILLIAM C JRDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001375 · doc4.xml · nonDerivative · entry 1 BALLARD WILLIAM C JR · CIK 0001024398 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,761 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:01 UTC |
BURKE RICHARD TDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001376 · doc4.xml · nonDerivative · entry 1 BURKE RICHARD T · CIK 0000905023 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,509,731 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:02 UTC |
DARRETTA ROBERT JDirector
|
GrantCommon Stock | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001378 · doc4.xml · nonDerivative · entry 1 DARRETTA ROBERT J · CIK 0001188999 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,510 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:02 UTC |
HOOPER MICHELE JDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001380 · doc4.xml · nonDerivative · entry 1 HOOPER MICHELE J · CIK 0001201723 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,181 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:03 UTC |
LAWSON RODGER ADirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001382 · doc4.xml · nonDerivative · entry 1 LAWSON RODGER A · CIK 0001187442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,130 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:03 UTC |
LEATHERDALE DOUGLAS WDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001385 · doc4.xml · nonDerivative · entry 1 LEATHERDALE DOUGLAS W · CIK 0001024367 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,676 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:04 UTC |
RENWICK GLENN MDirector
|
GrantCommon Stock | 1,336 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001388 · doc4.xml · nonDerivative · entry 1 RENWICK GLENN M · CIK 0001198119 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,210 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:04 UTC |
Shine Kenneth IrwinDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001393 · doc4.xml · nonDerivative · entry 1 Shine Kenneth Irwin · CIK 0001455025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,744 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| January 03, 2012 Filed Jan 4, 2012 22:05 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 729 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-001396 · doc4.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,651 F1 · shares: Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until departure from the Board. Read SEC document |
| December 30, 2011 Filed Mar 7, 2012 21:31 UTC |
HEMSLEY STEPHEN JDirector · President & Chief Exec Officer
|
GiftCommon Stock | 58,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-12-016550 · doc5.xml · nonDerivative · entry 1 HEMSLEY STEPHEN J · CIK 0001180162 · Director · President & Chief Exec Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,554,521.572 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.